Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Phenotypic and Proliferative Analysis of T Cell and Monocyte Populations in Patients with Intermediate/High/Very High-Risk MDS Compared to Age-Matched Healthy Donors

Hannah Fields, Valentina Ferrari, BA, Alison Tarke, BS, Randy Guo-Shi Tsai, BS, BA, Timothy Luger, Colin McCarthy, BS, Ruifeng Chen, Xinlian Zhang, Thomas A Lane, MD, Antonella Vitiello, Dr. Pharm., Rafael Bejar, MD PhD, Tiffany N Tanaka, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-142038

Published: 2020

Journal Articles

T Cell Activation By OKT3 Is a Function of the Percent Monocytes in PBMC of Healthy Donors and MDS Patients

Alison Tarke, Valentina Ferrari, BA, Hannah Fields, Luca Ferrari, Franco Ferrari, PhD, Tiffany N Tanaka, MD, Rafael Bejar, MD PhD, Antonella Vitiello, Dr. Pharm., Thomas A Lane, MD

Blood (2019) 134 (Supplement_1): 4870.

https://doi.org/10.1182/blood-2019-131474

Published: 2019

Journal Articles

A Phase 1 Clinical Trial of Personalized Adoptive Cellular Therapy Targeting Myelodysplastic Syndrome (MDS) Stem Cell Neoantigens (PACTN)

Valentina Ferrari, Tiffany N Tanaka, MD, Alison Tarke, Hanna Fields, Luca Ferrari, Alex Ni, Franco Ferrari, PhD, John Warner, PhD, Theresa Jochelson, Rafael Bejar, MD PhD, Antonella Vitiello, Dr. Pharm., Thomas A Lane, MD

Blood (2018) 132 (Supplement 1): 4373.

https://doi.org/10.1182/blood-2018-99-118834

Published: 2018

Journal Articles

Multiple Myeloma Cancer Stem Cell Animal Model.

Christina C.N. Wu, Ph.D., Daniel Jacob Goff, Wenxue Ma, Heather Leu, Thomas A. Lane, MD, Catriona H.M. Jamieson, MD, PhD, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA

Blood (2009) 114 (22): 1848.

https://doi.org/10.1182/blood.V114.22.1848.1848

Published: 2009

Journal Articles

Generation of Autologous Pre-B Acute Lymphocytic Leukemia (ALL) Reactive T Cell Lines Using ALL Blasts as Antigen Presenting Cells.

Rui-kun Zhong, MD, Thomas A. Lane, MD, Edward D Ball, MD

Blood (2009) 114 (22): 2035.

https://doi.org/10.1182/blood.V114.22.2035.2035

Published: 2009

Journal Articles

Characterization of Leukemic Stem Cells in a Newly Established Acute Myeloid Leukemia (AML) Cell Line 2006-5

Rui-kun Zhong, Thomas A. Lane, MD, Edward D Ball, MD

Blood (2008) 112 (11): 3987.

https://doi.org/10.1182/blood.V112.11.3987.3987

Published: 2008

Journal Articles

Approach to Establish Long Term Anti-Acute Myeloid Leukemia (AML) Immune Responses by Inducing Central Memory AML Specific CD4 T Cells.

Ruikun Zhong, MD, Thomas A. Lane, MD, Edward D Ball, MD

Blood (2008) 112 (11): 1956.

https://doi.org/10.1182/blood.V112.11.1956.1956

Published: 2008

Journal Articles

Feasibility of Rapidly Generating Sufficient Autologous Human Marrow Stromal Cells for Cellular Therapy.

Thomas A. Lane, MD, Davina Garls, BS, Ellen Mackintosh, MT, Sanjivan Kohli, MD, Steven C. Cramer, MD

Blood (2007) 110 (11): 1218.

https://doi.org/10.1182/blood.V110.11.1218.1218

Published: 2007

Journal Articles

Marrow Stromal Cell (MSC) Growth from Long Term Cryopreserved Bone Marrow.

Thomas A. Lane, MD, Davina Garls, B.S., Ellen Mackintosh, M.T., Steven C. Cramer, M.D.

Blood (2006) 108 (11): 5227.

https://doi.org/10.1182/blood.V108.11.5227.5227

Published: 2006

Journal Articles

Generation of Acute Myeloid Leukemia (AML)-Specific Autologous CD4 and CD8 T Cell Lines by Limiting Dilution AML Dendritic Cell Culture.

Rui-kun Zhong, MD, Thomas A. Lane, MD, Edward D. Ball, MD

Blood (2006) 108 (11): 2018.

https://doi.org/10.1182/blood.V108.11.2018.2018

Published: 2006

Journal Articles

BEAM Versus CEB Conditioning for Autologous Transplantation in Patients with Non-Hodgkin’s Lymphoma and Hodgkin’s Disease: A Single Center Comparative Study of 219 Patients.

Asad Bashey, MD, PhD, Oralia Loza, Bridget Medina, Katherine Keesee, PharmD, Sue Corringham, RN, Januario Castro, MD, Peter Holman, MD, Thomas A. Lane, MD, Edward D. Ball, MD, Ewa Carrier, MD

Blood (2005) 106 (11): 2079.

https://doi.org/10.1182/blood.V106.11.2079.2079

Published: 2005

Journal Articles

Intermediate Dose Cyclophosphamide Followed by Sequential GM-CSF and G-CSF: An Efficient and Predictable PBPC Mobilization Regimen for Autografting: A Single Center Study of Two Hundred and Thirty Patients.

Thomas A. Lane, MD, Lin Liu, PhD, Anita Ihasz, Bridget Medina, Sue Corringham, RN, Peter Holman, MD, Ewa Carrier, MD, Januario Castro, MD, Edward D. Ball, MD, Asad Bashey, MD

Blood (2005) 106 (11): 5281.

https://doi.org/10.1182/blood.V106.11.5281.5281

Published: 2005

NARROW

Phenotypic and Proliferative Analysis of T Cell and Monocyte Populations in Patients with Intermediate/High/Very High-Risk MDS Compared to Age-Matched Healthy Donors

T Cell Activation By OKT3 Is a Function of the Percent Monocytes in PBMC of Healthy Donors and MDS Patients

A Phase 1 Clinical Trial of Personalized Adoptive Cellular Therapy Targeting Myelodysplastic Syndrome (MDS) Stem Cell Neoantigens (PACTN)

Multiple Myeloma Cancer Stem Cell Animal Model.

Generation of Autologous Pre-B Acute Lymphocytic Leukemia (ALL) Reactive T Cell Lines Using ALL Blasts as Antigen Presenting Cells.

Characterization of Leukemic Stem Cells in a Newly Established Acute Myeloid Leukemia (AML) Cell Line 2006-5

Approach to Establish Long Term Anti-Acute Myeloid Leukemia (AML) Immune Responses by Inducing Central Memory AML Specific CD4 T Cells.

Feasibility of Rapidly Generating Sufficient Autologous Human Marrow Stromal Cells for Cellular Therapy.

Marrow Stromal Cell (MSC) Growth from Long Term Cryopreserved Bone Marrow.

Generation of Acute Myeloid Leukemia (AML)-Specific Autologous CD4 and CD8 T Cell Lines by Limiting Dilution AML Dendritic Cell Culture.

BEAM Versus CEB Conditioning for Autologous Transplantation in Patients with Non-Hodgkin’s Lymphoma and Hodgkin’s Disease: A Single Center Comparative Study of 219 Patients.

Intermediate Dose Cyclophosphamide Followed by Sequential GM-CSF and G-CSF: An Efficient and Predictable PBPC Mobilization Regimen for Autografting: A Single Center Study of Two Hundred and Thirty Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only